Could a headband at home keep depression away?
NCT ID NCT07269964
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a portable, at-home brain stimulation device (tDCS) can help people with depression maintain the improvements they achieved during hospital treatment with esketamine, rTMS, or ECT. Thirty adults will use the device for 30 minutes a day, five days a week, for four weeks. The main goal is to see if the home program is feasible and well tolerated, and whether depressive symptoms stay stable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could offer a convenient, home-based way to help people with depression keep their gains after intensive hospital treatment.
What could go wrong
This is a very small, early pilot study (30 people) with no placebo group. It only tests feasibility, not proven effectiveness. The device may cause mild tingling or skin redness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry and Psychotherapy, Technical University of Munich, University Hospital
RECRUITINGMünchen, 81675, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich,
ENROLLING_BY_INVITATIONMünchen, Bavaria, 81675, Germany